Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
Mayo Clinic - Scottsdale, Scottsdale, Arizona Del Sol Research Management, Tucson, Arizona Medical Associates Research Group, San Diego, California Digestive and Liver Center of Florida, Orlando, Florida Gastroenterology Health Partners, PLLC, New Albany, Indiana Tandem Clinical Research, Marrero, Louisiana Corewell Health (Spectrum Health Hospitals Colorectal Cancer Multis), Grand Rapids, Michigan Mayo Clinic - Rochester, Rochester, Minnesota Washington University School of Medicine, St Louis, Missouri University of Pennsylvania, Philadelphia, Pennsylvania Gastro One-8110 Walnut Rs, Cordova, Tennessee Vanderbilt Digestive Center, Nashville, Tennessee Genetic Cancer Prevention Clinic - UT Southwestern, Dallas, Texas MD Anderson Cancer Center, Houston, Texas Huntsman Cancer Institute and University of Utah, Salt Lake City, Utah Benaroya Research Institute at Virginia Mason, Seattle, Washington